– GEN’s Editor-in-Chief John Sterling talks with Jon J. Jonsson, M.D., Ph.D., from the University of Iceland.

Previous articleNew Breast Cancer Biomarkers Identified
Next articleMedImmune In-Licenses Novel Inflammatory Disease Target